Pharmaceutical compliance documentation in hours, not months.

Right now, pharma teams write and check regulatory documents by hand. That takes months.

Pharmable checks documents such as CSRs, CAPAs, deviations and dossier sections against the actual FDA, EMA and ICH rules and flags anything that would not pass before anyone signs off. The dashboard, document scanning and audit trail are live and working today.

Built to meet the rules you answer to

21 CFR Part 11EU GMP Annex 11GAMP 5GDPREU data residencySOC 2

The product today

It already works.

Upload a document and get it scanned against the rules that apply. See every finding with a severity badge and the exact citation behind it.

Preview coming soon

Compliance dashboard: upload and scan

Preview coming soon

Document detail: severity badge and citation

How it works

A document meets the standard, or it does not. Pharmable tells you before anyone signs off.

The check step is where problems slip through today. Teams are busy, older tools miss errors and documents that should fail still pass. That is how companies end up with FDA observations and warning letters. Pharmable runs that check automatically: it retrieves the exact rules for the document type, scans the text against them and flags any gap with a citation to the specific rule. Each customer runs in an isolated environment. No documents mix across customers, and nothing trains a shared model.

  1. 1

    Upload a document

    A CSR, CAPA, deviation or dossier section, from the dashboard

  2. 2

    It is scanned against the rules that apply

    The current FDA, EMA and ICH text for that document type

  3. 3

    Findings show with a severity badge and citation

    The exact clause behind each finding

  4. 4

    Every check is logged in a hash-chained audit trail

    Proof of what ran, when and against which rules

What we focus on

What matters most to the teams we build for.

01

Fast to launch

Teams are live in a few weeks. Projects like this usually take months before anyone sees value.

Live in weeks
02

Priced for growth

We are validating a target range of $50K to $100K a year with design partners before it becomes final pricing.

Working estimate

Why it matters

Every month earlier is a month of revenue.

In pharma, speed to market means real revenue. Every month a team files faster, safely and correctly, is a month their product earns revenue sooner. Speed only counts when the compliance is right, which is what the validation engine checks for.

Industry estimate: thousands of small and mid-size pharma and biotech companies need this today and have no good option.

$1M+ a day Estimated revenue lost per day a drug's launch is delayed
$250M to $800M Estimated addressable market a year, industry-wide
5,000 to 8,000 Target companies across the industry

Industry figures, based on public EMA/FDA registrant data, filing-delay estimates and published cost-of-delay analyses for drug launches.

Who is building this

Founders

Issam Arida

Issam Arida

Computer science and AI student with a passion for pharmacy. Started Pharmable after discovery interviews with regulatory affairs and distribution leads in Jordan's pharma industry.

issamaarida@gmail.com
Javi Cruz

Javi Cruz

Computer science and AI student with a passion for sales. Leads outreach across Mexico and Europe.

javiercruzvill123@gmail.com

Get in touch

Want to talk?

To learn more, or just to say hello, send us an email and we will get back to you.

Email us